Skip to main content

Table 4 Diagnostic assessment and laboratory findings in pediatric patients with paroxysmal sympathetic hyperactivity

From: Clinical characteristics, diagnostic challenges, and outcome of paroxysmal sympathetic hyperactivity in pediatric patients: a retrospective cohort study in a tertiary hospital setting

Variables (N = 42)

Counts

% of Total

PSH-AM use

Performed

22

52.4%

Not done

20

47.60%

PSH-AM score (N = 22)

Mean (SD)

21.05

6.904

Median (IQR)

21

(17, 24)

Onset of diagnosis

Mean (SD)

3.76

2.92

Median (IQR)

2.96

(1.71, 5)

CBC

Normal

33

78.6%

Abnormal

9

21.4%

LFT

Normal

26

61.9%

Abnormal

16

38.1%

ESR

Normal

21

50.0%

Abnormal

15

35.7%

Not done

6

14.3%

CRP (N = 41)

Normal

20

48.8%

Abnormal

17

41.5%

Not done

4

9.8%

Blood culture

Normal

37

88.1%

Abnormal

5

11.9%

Urine culture

Normal

38

90.5%

Abnormal

4

9.5%

CSF culture

Normal

27

64.3%

Abnormal

1

2.4%

Not done

14

33.3%

Respiratory culture

Normal

22

52.4%

Abnormal

11

26.2%

Not done

9

21.4%

ECG findings

Normal

21

50.0%

Not done

10

23.8%

Sinus tachycardia

9

21.4%

Sinus rhythm with 1st degree block

1

2.4%

Right bundle branch block

1

2.4%

EEG findings

Normal

3

7.1%

Not done

7

16.7%

Slow background

15

35.7%

Slow background with epileptiform discharge

13

31%

Seizure

4

9.5%

MRI findings

Ischemic changes

8

19.04%

hemorrhage

3

7.14%

herniation

1

2.38%

volume loss

11

26.19%

profound HIE

8

19.04%

Demyelination

8

19.04%

Diffuse axonal injury

3

7.14%

Congenital anomaly

4

9.52%

autoimmune encephalitis

1

2.38%

ECHO findings

Normal

18

41.9%

Not done

11

25.6%

Abnormal

13

30.9%

Structural

9

20.9%

Valvular

2

4.7%

Functional

2

4.8%